Vigeo Therapeutics is a clinical stage company developing novel therapeutic agents for the treatment of cancer.
External link for Vigeo Therapeutics
545 Concord Ave
Cambridge, Massachusetts 02138, US
Vigeo Therapeutics reposted this
Proud of the Vigeo Therapeutics team our work on tumor microenvironment modulator VT1021 that is now published in Nature Communications Medicine. Great work by a great team. https://lnkd.in/eaa4_YV9
Proud of the Vigeo Therapeutics team our work on tumor microenvironment modulator VT1021 that is now published in Nature Communications Medicine. Great work by a great team. https://lnkd.in/eaa4_YV9
I am so proud to be part of team that has been working to find cures for GBM. #GoGrayInMay
In honor of Brain Cancer Awareness Month Vigeo Therapeutics supports the scientists, patients and physicians and their efforts to find therapies to treat brain tumors. #GoGrayInMay #GBM #Glioblastoma
In honor of Brain Cancer Awareness Month Vigeo Therapeutics supports the scientists, patients and physicians and their efforts to find therapies to treat brain tumors. #GoGrayInMay #GBM #Glioblastoma
Don't forget to join Vigeo Therapeutics COO Dr. Jing Watnick updating the Fifth Annual Glioblastoma Drug Development Summit TODAY at 1:30 PM EDT today (March 28) in Boston, MA. Dr. Watnick will give an overview of #VT1021 in our Ph1/2 program in GBM as well as the future use of #VT1021 in attacking the roots of Neuro-inflammatory disease #GBM #Glioblastoma #NeurodegenerativeDisease #NeuroInflammatoryDisease #GBMSummit
Don't miss the #VT1021 update from Vigeo Therapeutics COO Dr. Jing Watnick at the Fifth Annual Glioblastoma Drug Development Summit in Boston MA this week. Dr. Watnick will be speaking during the afternoon session on 28 March on The #VT1021 Ph1/2 clinical program in #glioblastoma as well the potential future use of #VT1021 in Neuro-inflammatory diseases #GBM #Glioblastoma #NeuroinflammatoryDiseases #VT1021
Vigeo Therapeutics reposted this
Dr. Suming Wang of Vigeo Therapeutics presented a poster at the Crohn's and Colitis Congress in Las Vegas NV studying VT1021 efficacy in IBD models in mice. #VT1021 #TSP1 #IBD #crohnsdisease #cccongress24 https://lnkd.in/eaEk-iUN
Vigeo Therapeutics reposted this
Experienced biotech veteran with more than 15 years of Program Leadership and Operations experience across all functions of both start-ups and larger established companies.
Great story about a patient treated for GBM with #VT1021. https://lnkd.in/ewnCrZ2X
Experienced biotech veteran with more than 15 years of Program Leadership and Operations experience across all functions of both start-ups and larger established companies.
Great story about a patient treated for GBM with #VT1021. https://lnkd.in/ewnCrZ2X
Dr. Suming Wang of Vigeo Therapeutics presented a poster at the Crohn's and Colitis Congress in Las Vegas NV studying VT1021 efficacy in IBD models in mice. #VT1021 #TSP1 #IBD #crohnsdisease #cccongress24 https://lnkd.in/eaEk-iUN